PCO371
Lintlha tsa Sehlahisoa
Li-tag tsa Sehlahisoa
Boholo ba Pakete | Ho fumaneha | Theko (USD) |
Lebitso la lik'hemik'hale:
1-(3,5-dimethyl-4-(2-((4-oxo-2-(4-(trifluoromethoxy)phenyl))-1,3,8-triazaspiro[4.5]dec-1-en-8-yl )sulfonyl)ethyl)phenyl)-5,5-dimethylimidazolidine-2,4-dione
SMILES Khouto:
O=C1NC(C(C)(C)N1C2=CC(C)=C(CCS(=O)(N(CC3)CCC3(N=C(C4=CC=C(OC(F)(F)F )C=C4)N5)C5=O)=O)C(C)=C2)=O
Khoutu ea InChi:
InChI=1S/C29H32F3N5O6S/c1-17-15-20(37-26(40)34-24(38)27(37,3)4)16-18(2)22(17)9-14-44( 41,42)36-12-10-28(11 -13-36)25(39)33-23(35-28)19-5-7-21(8-6-19)43-29(30,31)32/h5-8,15-16H,9 -14H2,1-4H3,(H,33,35,39)(H,34,38,40)
InChi Key:
LTZJFVOUPUFOHX-UHFFFAOYSA-N
Keyword:
PCO371; PCO-371; PCO 371
Sollubility:
Polokelo:
Tlhaloso:
PCO371 ke agonist e matla le e khethang ea PTHR1 bakeng sa kalafo ea hypoparathyroidism. Tsamaiso ea molomo ea PCO371 ho likhoto tsa osteopenic e baka keketseho e kholo ea phetoho ea masapo le keketseho e fokolang ea masapo. Likhotong tsa hypocalcemic, PCO371 e tsosolosa maemo a calcium ea serum ntle le ho eketsa khalsiamo ea urinary, le ka liphello tse matla le tse tšoarellang nako e telele ho feta liente tsa PTH.
Sepheo: PTHR1